Cortria Corporation
Boston, Massachusetts, United States
About Cortria Corporation
Cortria Corporation, a pharmaceutical company, develops medicines for the treatment of cardiovascular diseases. Its product is used for the treatment of dyslipidemia, an atherogenic disorder characterized by abnormal lipid levels in the bloodstream. The company was founded in 2005 and is based in Boston, Massachusetts. As of August 24, 2010, Cortria Corporation operates as a subsidiary of DERMENA North America Inc.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $10K – $50K
- Total funding: $1.8M
- Last round: Series Unknown (Jun 2009)
- Website: cortria.com
Industries & Categories
Biotechnology, Medical, Pharmaceutical
Canonical: https://fsome.com/organization/cortria-corporation-2484449 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.